The impact of psychostimulant use on office based buprenorphine treatment retention

This study examined the impact of stimulant use on retention in buprenorphine treatment within a low-threshold OBOT clinic. Our findings differ from previous research that reported significant decreases in retention among methamphetamine users. Instead, results suggest that patients using psychostimulants can be effectively retained in care within a low-resource, low-threshold setting, though increased clinical engagement may be beneficial for those testing positive for cocaine or methamphetamine. Given the limited access to buprenorphine treatment, these findings underscore the urgent need for expanded, accessible treatment models that can effectively serve individuals with co-occurring stimulant use.

Authors

Institutions

Publication Details

Journal
Harm Reduction Journal
Published
2025-04-11
DOI
https://doi.org/10.1186/s12954-025-01201-3
Citations
1
Primary Topic
Opioid Use Disorder Treatment
Type
article
Field-Weighted Citation Impact
1.88
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The impact of psychostimulant use on office based buprenorphine treatment retention

Veeraj Shah, Lisa Bell, KEVIN BEACH, Sam MacMaster et al.
1 citations
Harm Reduction Journal
Opioid Use Disorder Treatment
1.88
article

The impact of psychostimulant use on office based buprenorphine treatment retention

Veeraj Shah, Lisa Bell, KEVIN BEACH, Sam MacMaster, Peter F. Rebeiro, Ryan Edgerton, Robert Lyle Cooper, Parul Patel, Loren Ginn
article en
1 citations

Abstract

This study examined the impact of stimulant use on retention in buprenorphine treatment within a low-threshold OBOT clinic. Our findings differ from previous research that reported significant decreases in retention among methamphetamine users. Instead, results suggest that patients using psychostimulants can be effectively retained in care within a low-resource, low-threshold setting, though increased clinical engagement may be beneficial for those testing positive for cocaine or methamphetamine. Given the limited access to buprenorphine treatment, these findings underscore the urgent need for expanded, accessible treatment models that can effectively serve individuals with co-occurring stimulant use.

Harm Reduction JournalVol. 22(1)
Meharry Medical College (US), Vanderbilt University (US), Vanderbilt University Medical Center (US), The University of Texas Health Science Center at Houston (US)
Openalex Percentile: Top 17%
Opioid Use Disorder Treatment
1.88
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.